Anti-miR-134-3p decreased miR-134-3p levels (Fig. 7A), whereas the LASP1 overexpression plasmid, pcDNA3.1-LASP1, increased LASP1 levels in breast cancer cells (Fig. 7B). This evidence concerns the gene LASP1 and breast carcinoma.